Medtronic manufactures and sells device-based medical therapies. Its products include pacemakers, insertable cardiac monitors, implantable defibrillators, leads and delivery systems, ablation products, electrophysiology catheters, coronary and peripheral stents and related delivery systems, therapies for uncontrolled hypertension, endovascular stent graft systems, heart valve replacement technologies, and cardiac tissue ablation systems. The Company also manufactures image-guided surgery and intra-operative imaging systems.

Employee Rating

3.6More
TypePublic
HQMinneapolis, US
Founded1949
Size (employees)86,000 (est)
Websitemedtronic.com
Medtronic was founded in 1949 and is headquartered in Minneapolis, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Medtronic

Omar Ishrak

Omar Ishrak

CEO, Chairman
Karen Parkhill

Karen Parkhill

EVP, CFO
Richard Kuntz

Richard Kuntz

SVP, Chief Medical and Scientific Officer
Carol Surface

Carol Surface

SVP and Chief Human Resources Officer
Show more

Medtronic Office Locations

Medtronic has offices in Minneapolis, Doral, Tempe, Tampa and in 83 other locations
Minneapolis, US (HQ)
710 Medtronic Parkway
Doral, US
450 9850 NW 41st St
Doral, US
9850 NW 41st Street, Suite 450
Miami, US
Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
Plymouth, US
3800 Annapolis Ln N #175
Portsmouth, US
180 International Dr
Show all (95)
Report incorrect company information

Medtronic Financials and Metrics

Medtronic Revenue

Embed Graph
View revenue for all periods
Medtronic's revenue was reported to be $29.95 b in FY, 2018 which is a 0.8% increase from the previous period.
USD

Revenue (Q2, 2019)

7.5b

Gross profit (Q2, 2019)

5.3b

Gross profit margin (Q2, 2019), %

70.6%

Net income (Q2, 2019)

1.1b

EBIT (Q2, 2019)

1.5b

Market capitalization (17-Jan-2019)

117.7b

Closing stock price (17-Jan-2019)

87.6

Cash (26-Oct-2018)

3.9b

EV

137.4b
Medtronic's current market capitalization is $117.7 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

17.0b20.3b28.8b29.7b30.0b

Revenue growth, %

19%42%3%1%

Cost of goods sold

4.3b6.3b9.1b9.3b9.1b

Gross profit

12.7b14.0b19.7b20.4b20.9b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

7.3b7.1b6.9b7.2b7.3b7.3b7.4b7.1b21.8b7.4b7.5b

Cost of goods sold

2.5b2.2b2.1b2.3b2.3b2.3b2.3b2.1b6.7b2.2b2.2b

Gross profit

4.8b4.9b4.8b4.9b5.0b5.0b5.0b4.9b15.1b5.2b5.3b

Gross profit Margin, %

66%69%69%68%68%69%68%70%69%70%71%
Annual
USDY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

13.2m4.8b186.4m5.0b3.7b

Accounts Receivable

17.1m5.6b6.0b

Inventories

1.7b3.5b3.5b3.3b3.6b

Current Assets

21.2b30.8b23.6b24.9b23.0b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

46.0k3.0b2.4b2.7b3.1b3.0b2.8b4.7b5.5b6.4b4.4b3.9b

Accounts Receivable

(68.0m)

Inventories

3.4b3.5b3.5b3.6b3.7b3.7b3.5b3.8b3.7b3.8b

Current Assets

46.0k29.1b28.7b27.6b23.5b22.5b22.4b24.8b25.2b26.6b22.5b21.7b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

3.1b2.7b3.5b4.0b3.1b

Depreciation and Amortization

349.0m1.3b2.8b2.0b2.6b

Inventories

(39.0m)(282.0m)(186.0m)(227.0m)(192.0m)

Accounts Payable

Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(37.1m)820.0m1.3b2.4b929.0m2.0b2.9b1.0b3.0b1.6b1.1b2.2b

Depreciation and Amortization

701.0m1.4b2.1b737.0m1.5b2.2b636.0m1.3b2.0b666.0m1.3b

Inventories

(207.0m)(326.0m)(388.0m)(101.0m)(187.0m)(261.0m)(273.0m)(318.0m)(180.0m)(312.0m)

Accounts Payable

1.3b1.4b1.4b(307.0m)13.0m85.0m24.0m
USDY, 2018

EV/EBIT

89 x

EV/CFO

48 x

Financial Leverage

1.8 x
Show all financial metrics

Medtronic Operating Metrics

Medtronic's Patients was reported to be 65 m in FY, 2016.
FY, 2014FY, 2015FY, 2016

Countries

160 160

Patents Issued

27 k53 k45 k

Patients

65 m
Show all operating metrics

Medtronic Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
NutrinoNovember 30, 2018
Mazor RoboticsSeptember 21, 2018$1.64 b
Visionsense LtdApril 11, 2018$75 m

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

Human Capital Metrics

Medtronic's employees are reported to be approximately 49% female and 51% male.
Embed Graph
Show all human capital metrics
Report incorrect company information

Medtronic Online and Social Media Presence

Embed Graph
Report incorrect company information

Medtronic News and Updates

Global $2.9 Bn Hydroxyapatite Market to 2023: Investments by Major Players like Zimmer Biomet, Johnson & Johnson and Medtronic to Positively Influence the Market

DUBLIN, Jan. 17, 2019 /PRNewswire/ -- The "Global Hydroxyapatite Market By Type (Nano-sized, Micro-sized and Greater than Micrometer), By Application (Orthopedic, Plastic Surgery, Dental Care and Others), By Region, Competition, Forecast & Opportunities, 2013-2023" report has been added...

Urology Surgical Instrument: Worldwide Market Outlook to 2024, Featuring Karl Storz, Olympus, Coloplast, Richard Wolf, Medtronic, and many more

DUBLIN, Jan. 17, 2019 /PRNewswire/ -- The "Global Urology Surgical Instrument Market by Product, by Application - Size, Share, Development, Growth and Demand Forecast by 2018-2024" report has been added to ResearchAndMarkets.com's offering. Global Urology Surgical Instrument market report ...

Global Pressure Monitoring Devices Market Forecasts and Opportunities 2019: Key Players - Hill-Rom, Philips Healthcare, GE Healthcare, Medtronic, A&D Medical, Dragerwerk

WiseGuyReports has added a new market intelligence report titled “Global Pressure Monitoring Devices Market Forecasts and Opportunities 2019: Key Players - Hill-Rom, Philips Healthcare, GE Healthcare, Medtronic, A&D Medical, Dragerwerk” to its storehouse of extensive and wide variety of reports.…

Explosive growth on Global Flash glucose monitoring system Market 2019 | Senseonics, Animas, Dexcom, Glysens, Medtronic, Omnipod, Roche, Ypsomed

Flash glucose monitoring is the latest method of glucose testing, which appears to be a hybrid between the meter and the CGM. In Flash Glucose Monitoring, patients inserted the sensor into a separate touchscreen reader device. Posted via Industry Today. Follow us on Twitter @IndustryToday

Medtronic debuts first apps to let heart patients monitor their pacemakers

In a world's first, a leading pacemaker manufacturer will enable patients to see the status of their heart implants using popular smartphones and tablets.

Neuromodulation Market 2023 report provides Latest improvements in the industry by anticipating the future perspective of the market, competitors, the top key players such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC

The Global Neuromodulation Market is an analysis and portrayal of the market globally. It gives a clear image of the market and a thoughtful knowledge about its segments. The various sections are examined and is the key part of the Neuromodulation Market. Posted via Industry Today. Follow us on Twit…
Show more
Report incorrect company information

Medtronic Company Life and Culture

Report incorrect company information

Medtronic Frequently Asked Questions

  • When was Medtronic founded?

    Medtronic was founded in 1949.

  • Who are Medtronic key executives?

    Medtronic's key executives are Omar Ishrak, Karen Parkhill and Richard Kuntz.

  • How many employees does Medtronic have?

    Medtronic has 86,000 employees.

  • What is Medtronic revenue?

    Latest Medtronic annual revenue is $30 b.

  • What is Medtronic revenue per employee?

    Latest Medtronic revenue per employee is $348.3 k.

  • Who are Medtronic competitors?

    Competitors of Medtronic include Olympus Corporation, Nikkiso and Boston Scientific.

  • Where is Medtronic headquarters?

    Medtronic headquarters is located at 710 Medtronic Parkway, Minneapolis.

  • Where are Medtronic offices?

    Medtronic has offices in Minneapolis, Doral, Tempe, Tampa and in 83 other locations.

  • How many offices does Medtronic have?

    Medtronic has 95 offices.